MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SIEGEL, G. J.
Right arrow Articles by FOGT, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SIEGEL, G. J.
Right arrow Articles by FOGT, S. K.

Molecular Pharmacology, Vol 15, 43-48, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Effects of Pb++ and other Divalent Cations on Ouabain Binding to E. electricus Electroplax (Na+ + K+)-Adenosinetriphosphatase

GEORGE J. SIEGEL 1 and SUZANNE K. FOGT 1

1 Neurology Research Laboratory, Neurology Department, University of Michigan Medical School, Ann Arbor, Michigan 48109

PbCl2 reduces the level of [3H]ouabain binding to (Na+ + K+)-adenosinetriphosphatase in E. electricus electroplax microsomal preparations in the presence of Mg++ and ATP with or without Na+. The inhibition is competitive with ATP, and Na+ is cooperative with Pb++ in reducing the affinity for ATP at a site involved in ouabain binding. The ATP site involved in ouabain binding is not the substrate site since no such cooperative interactions among Pb++, Na+, and ATP could be observed with regard to phosphorylation or inhibition of hydrolysis. ADP also stimulates ouabain binding, which is inhibited competitively by Pb++. Cd++, Cu++, Hg++, and Zn++ also inhibit ouabain binding in the presence of Mg++, ATP, with or without 50 mM Na+ but only the inhibition by Cd++ is potentiated by 50 mM Na+. BaCl2, FeCl2, CaCl2, MnC12, NiCl2, CoC12, and SrCl2 at concentrations of 60 µM did not inhibit drug binding.

Submitted on May 15, 1978
Accepted on August 10, 1978







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics